Literature DB >> 32277760

Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis.

Alessandro Casini1, Lorenzo Alberio2, Anne Angelillo-Scherrer3, Pierre Fontana1, Bernhard Gerber4, Lukas Graf5, Inga Hegemann6, Wolfgang Korte5, Johanna Kremer Hovinga3, Thomas Lecompte6, Maria Martinez7, Michael Nagler8, Jan-Dirk Studt6, Dimitrios Tsakiris8, Walter Wuillemin9, Lars Asmis10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32277760     DOI： 10.4414/smw.2020.20247

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN： 0036-7672            Impact factor:   2.193


× No keyword cloud information.
  30 in total

1.  COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.

Authors:  Antonio Coppola; Maria Lombardi; Maria I Tassoni; Gaetano Carolla; Maurizio Tala; Rossella Morandini; Oriana Paoletti; Sophie Testa
Journal:  Blood Transfus       Date:  2020-05       Impact factor: 3.443

2.  Association of D-dimer and Fibrinogen With Hypercoagulability in COVID-19 Requiring Extracorporeal Membrane Oxygenation.

Authors:  Abhimanyu Chandel; Saloni Patolia; Mary Looby; Najeebah Bade; Vikramjit Khangoora; Christopher S King
Journal:  J Intensive Care Med       Date:  2021-03-01       Impact factor: 3.510

3.  Better Anticoagulated Than Not! Hypercoagulability in COVID-19.

Authors:  Dhauna P Karam
Journal:  JCO Oncol Pract       Date:  2021-06-16

Review 4.  A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population.

Authors:  Kai Chin Poh; Victoria Yu Jia Tay; Sarah Huixin Lin; Huei Leng Chee; Suhitharan Thangavelautham
Journal:  Singapore Med J       Date:  2022-07       Impact factor: 3.331

Review 5.  Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy.

Authors:  Alla Turshudzhyan
Journal:  Cureus       Date:  2020-05-16

Review 6.  Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.

Authors:  Giovanni Ostuzzi; Davide Papola; Chiara Gastaldon; Georgios Schoretsanitis; Federico Bertolini; Francesco Amaddeo; Alessandro Cuomo; Robin Emsley; Andrea Fagiolini; Giuseppe Imperadore; Taishiro Kishimoto; Giulia Michencigh; Michela Nosé; Marianna Purgato; Serdar Dursun; Brendon Stubbs; David Taylor; Graham Thornicroft; Philip B Ward; Christoph Hiemke; Christoph U Correll; Corrado Barbui
Journal:  BMC Med       Date:  2020-07-15       Impact factor: 8.775

Review 7.  Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review.

Authors:  Kamal Matli; Raymond Farah; Mario Maalouf; Nibal Chamoun; Christy Costanian; Georges Ghanem
Journal:  Open Heart       Date:  2021-06

8.  Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19.

Authors:  Christopher Hughes; Tom Nichols; Martin Pike; Christian Subbe; Salah Elghenzai
Journal:  Eur J Case Rep Intern Med       Date:  2020-04-29

Review 9.  COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.

Authors:  Antonis S Manolis; Theodora A Manolis; Antonis A Manolis; Despoina Papatheou; Helen Melita
Journal:  J Cardiovasc Pharmacol Ther       Date:  2020-09-14       Impact factor: 2.457

Review 10.  COVID-19, coagulopathy and venous thromboembolism: more questions than answers.

Authors:  Marco Marietta; Valeria Coluccio; Mario Luppi
Journal:  Intern Emerg Med       Date:  2020-07-11       Impact factor: 5.472
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.